Monty K. Allen - 07 Dec 2025 Form 4 Insider Report for IRADIMED CORP (IRMD)

Role
Director
Signature
/s/ Monty K. Allen
Issuer symbol
IRMD
Transactions as of
07 Dec 2025
Net transactions value
$0
Form type
4
Filing time
09 Dec 2025, 17:00:09 UTC
Previous filing
06 Aug 2025
Next filing
15 Dec 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
ALLEN MONTY K Director C/O IRADIMED CORPORATION, 12705 INGENUITY DRIVE, ORLANDO /s/ Monty K. Allen 09 Dec 2025 0001253352

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction IRMD Common Stock Options Exercise +1,197 +6% 21,095 07 Dec 2025 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction IRMD Restricted Stock Units Options Exercise $0 -1,197 -100% $0.000000 0 07 Dec 2025 Common Stock 1,197 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Restricted stock units convert into common stock on a one-for-one basis.
F2 On December 7, 2023, the reporting person received restricted stock units under Iradimed Corporation's 2023 Equity Incentive Plan. The restricted stock units vest in two equal annual installments beginning on December 7, 2024. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested.